Wosulin 30/70 40IU/ml Injection
By Wosulin
Rx
10ml Injection in a Vial

Composition
Insulin Isophane/NPH(70%) + Human Insulin/Soluble Insulin(30%)

Manufacturer - Wockhardt Ltd
Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India

Expires on or after
December, 2026
About Wosulin 30/70 40IU/ml Injection
Wosulin 30/70 40IU/ml Injection is a combination of two types of insulin - intermediate-acting and short-acting. It is primarily used in the management of diabetes mellitus (both type 1 and type 2) to help control blood sugar levels in both adults and children with diabetes. This medication is usually prescribed along with other diabetes treatments and is administered by injection under the skin. Timing is crucial when taking Wosulin 30/70 40IU/ml Injection; it should be taken 15 minutes before a meal or within 20 minutes after starting a meal. It is important not to discontinue this medication without consulting your healthcare provider.
In addition to using Wosulin 30/70 40IU/ml Injection, a comprehensive treatment plan for diabetes should also include adherence to a healthy diet, regular physical activity, and weight management as recommended by your doctor. Regular monitoring of blood sugar levels is essential to determine the appropriate dosage of the medication for each individual. The common side effect associated with Wosulin 30/70 40IU/ml Injection is low blood sugar levels (hypoglycemia), which can be prevented by ensuring the correct dosage, regular meals, and consistent monitoring of blood sugar levels. Alcohol consumption should also be moderated as it can affect blood sugar levels. Other potential side effects may include reactions at the injection site, weight gain, rash, swelling, or itching.
Biphasic Isophane Insulin is the active ingredient in Wosulin 30/70 40IU/ml Injection, classified under Antidiabetic agents. It aids in regulating blood glucose levels by facilitating the transportation of glucose from the bloodstream to muscle and fat tissues. This pre-mixed insulin combines Regular (soluble) insulin and Isophane (NPH) insulin, acting rapidly to lower blood sugar levels within 30 minutes. To optimize its effects, it is advised to inject the medication 30 minutes before a meal and ensure timely consumption of meals thereafter.
Before initiating treatment with Wosulin 30/70 40IU/ml Injection, individuals with liver, kidney, or heart conditions should consult their healthcare provider. Patients with hormonal issues, recent dietary changes, or intense physical activity should also seek medical advice prior to using this medication. Avoid using Wosulin 30/70 40IU/ml Injection in cases of hypoglycemia and consult a healthcare professional if pregnant or nursing. Common side effects may include low blood sugar levels, injection site reactions, skin issues, and localized swelling. Notify your doctor if any side effects become bothersome.
Benefits
Wosulin 30/70 40IU/ml Injection offers a range of benefits for individuals dealing with diabetes. By containing both intermediate-acting and short-acting insulin types, this medication works synergistically to provide rapid and consistent control over blood sugar levels throughout the day. Proper administration, usually through injection, as instructed by your healthcare provider, ensures effective utilization of this medication. By effectively managing blood glucose levels, Wosulin 30/70 40IU/ml Injection helps in reducing the risk of developing severe diabetic complications such as kidney damage, eye problems, nerve issues, and limb loss.
The mechanism of action of Wosulin 30/70 40IU/ml Injection involves facilitating the uptake of sugar in muscle and fat cells while also inhibiting excessive sugar production in the liver. This dual-action not only helps in controlling blood sugar levels but also prevents the onset of serious diabetes-related complications. Additionally, this medication can be safely prescribed to pregnant and lactating diabetic women, making it a versatile option for managing blood sugar levels during crucial life stages.
Regular use of Wosulin 30/70 40IU/ml Injection, in combination with a suitable diet and exercise regimen, contributes to improved glycemic control. By maintaining stable blood sugar levels, this medication aids in decreasing the risk of complications such as retinopathy, nephropathy, neuropathy, delayed wound healing, diabetic foot ulcers, and more. Ultimately, including Wosulin 30/70 40IU/ml Injection as part of your diabetes management plan can help you lead a normal, healthy life by effectively controlling blood sugar levels and reducing the risk of severe diabetic complications.
How to use the Wosulin 30/70 40IU/ml Injection
To properly use Wosulin 30/70 40IU/ml Injection, it is essential to have your doctor or nurse administer the medicine. Please do not try to inject it yourself. The injection should never be given directly into a vein; it is meant to be injected under the skin in the abdomen or thigh area. If you are not confident in self-administering, seek help from a healthcare professional.
Under careful medical supervision, inject Wosulin 30/70 40IU/ml Injection into your thighs, buttocks, upper arm, or abdomen, subcutaneously, which means under the skin. Make sure not to inject it into a vein or muscle. It's recommended to administer this medication at least 10 minutes before meals, followed by consuming a meal or snack with carbohydrates within 20 minutes to prevent low blood sugar.
Before using the injection, gently roll the vial or cartridge between your hands until the liquid appears uniformly white and cloudy. When injecting, ensure the needle remains under the skin for at least 6 seconds to ensure the entire dose is delivered.
Always inspect the vial or cartridge for any visible particles or discoloration before administration. Dispose of the needle and syringe properly after use and never share them with others to avoid infections transmission. To prevent skin damage, avoid injecting the medication at the same site repeatedly; rotate the injection sites. Consult your doctor before changing the injection site for safety measures.
Do not mix Insugen 30/70 100IU/ml with any other insulins before use. Do not discontinue the therapy without consulting your doctor first. Your doctor will determine the correct dose and administration frequency based on factors like your age, body weight, and overall health condition.
Uses of Wosulin 30/70 40IU/ml Injection
Wosulin 30/70 40IU/ml Injection is primarily used for the treatment of diabetes, including Type 1 and Type 2 diabetes mellitus. It plays a crucial role in improving glycemic control in patients with diabetes. By effectively managing blood sugar levels, Wosulin 30/70 40IU/ml Injection helps patients maintain better overall health and well-being. This medication is especially beneficial for individuals with diabetes who struggle to control their blood sugar through other means. It is an important tool in the management of diabetes, offering patients a reliable way to regulate their condition and reduce the risk of complications associated with uncontrolled blood sugar levels.
What conditions Wosulin 30/70 40IU/ml Injection treats?
Wosulin 30/70 40IU/ml Injection is used to treat diabetes. Diabetes is a condition where the body either does not produce enough insulin (Type 2) or does not produce any insulin at all (Type 1). Insulin is needed to regulate blood sugar levels in the body. In Type 1 diabetes, the body cannot make insulin, while in Type 2 diabetes, the body either does not produce enough insulin or is resistant to its effects. Wosulin 30/70 40IU/ml Injection helps to provide the necessary insulin to help control blood sugar levels in diabetes patients.
Should you consult a doctor?
It is important to seek a doctor's advice before using Wosulin 30/70 40IU/ml Injection if you have issues with your adrenal, pituitary, or thyroid glands, or if you have made changes to your diet or exercise routine. If you are ill, have had infections recently, or are planning to travel abroad, it is recommended to consult with a healthcare provider before using this medication. Additionally, if you are at risk of developing hypoglycemia (low blood sugar levels), it is not advisable to use this injection without medical guidance. Monitoring your health and seeking medical advice in these situations is crucial for safe and effective treatment with Wosulin 30/70 40IU/ml Injection.
Side effects of Wosulin 30/70 40IU/ml Injection
Wosulin 30/70 40IU/ml Injection may cause side effects in some individuals. Common side effects include hypoglycemia, which is low blood glucose levels. You may also experience injection site reactions such as pain, swelling, or redness, as well as weight gain. Allergic reactions at the injection site, itching, lipodystrophy (skin thickening or pits), and edema (swelling) are also possible side effects. Other reactions may include rashes, weight gain, diabetic retinopathy (eye diseases related to diabetes), swelling around the ankles and joints, and painful neuropathy from nerve damage.
In some cases, you may notice lumps under the skin, shrinkage of fat tissues (lipodystrophy), and swelling in certain body parts. Ongoing side effects like these deserve attention from your doctor. It is important to report any severe side effects immediately, such as allergic reactions with skin rashes, itching, and difficulty breathing, or signs of severe hypoglycemia like cold sweats, rapid heartbeat, or changes in vision. Remember, always consult your doctor if you have concerns about any side effects from using Wosulin 30/70 40IU/ml Injection.
Safety advice

liver
When considering the use of Wosulin 30/70 40IU/ml Injection in individuals with liver disease, caution is advised. It may be necessary to adjust the dosage of Wosulin 30/70 40IU/ml Injection in such patients. It is important to consult with your doctor regarding the appropriate dosage adjustments. Regular monitoring of glucose levels is also recommended to ensure effective management of insulin therapy in individuals with liver issues.

kidney
Wosulin 30/70 40IU/ml Injection should be used carefully in patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Regularly monitor blood glucose levels for appropriate dosing.

alcohol
It is unsafe to drink alcohol with Wosulin 30/70 40IU/ml Injection.

driving
When your blood sugar is too low or too high, driving may be affected. Avoid driving if you experience these symptoms.

pregnancy
Wosulin 30/70 40IU/ml Injection is generally considered safe to use during pregnancy. Animal studies show minimal adverse effects on the developing baby, but human studies are limited.

breastfeeding
Wosulin 30/70 40IU/ml Injection is safe to use while breastfeeding. Studies show it does not pass into breastmilk in harmful amounts, posing no risk to the baby.
Age above 75(Geriatrics)
Wosulin 30/70 40IU/ml Injection should be used with caution in elderly patients (aged 65 years or above). Therefore, consult your doctor before administration. Proper dose adjustments and careful monitoring of blood glucose levels and kidney functions are required in such patients.
Age below 6 months(Pediatrics)
Wosulin 30/70 40IU/ml Injection can be used in children and adolescents (aged below 18 years) if prescribed by the physician. Therefore, consult your doctor before administration.
Consumption warning before consuming Wosulin 30/70 40IU/ml Injection
Before using Wosulin 30/70 40IU/ml Injection, it is crucial to note that this medication should only be administered under the skin (subcutaneously) and should never be injected into the veins (intravenously). If you are switching to this brand of insulin, it must be done with the supervision of a medical professional.
There have been reported cases of heart failure when pioglitazone is used along with insulin, particularly in patients at high risk of cardiac issues. Recognizing the early signs of high blood sugar (hyperglycemia) such as extreme thirst, frequent urination, nausea, dry skin, and loss of appetite is essential for monitoring your condition.
Symptoms like heart failure, weight gain, and fluid retention should not be ignored. Avoid alcohol consumption as it can raise blood sugar levels. Be cautious when traveling across multiple time zones, as your doctor may need to adjust your insulin regimen to suit the changes. It is vital to be aware that this medication may reduce potassium levels, leading to serious complications if left untreated, such as respiratory weakness, irregular heartbeat, and coma. Avoid using this medication if you have low blood sugar levels, or if you have kidney, liver, or heart conditions, as well as issues with alcohol or other recreational drugs.
What if you forgot to take Wosulin 30/70 40IU/ml Injection?
If you forget to take a dose of Wosulin 30/70 40IU/ml Injection, it can lead to increased blood sugar levels, known as hyperglycemia. To manage this, it's important to check your blood sugar level as soon as you realize you missed a dose. Based on your blood sugar reading, you can then take the next dose as prescribed. Monitoring your blood sugar levels is crucial in ensuring you maintain control over your diabetes and prevent any complications associated with missed doses. Remember to follow your healthcare provider's instructions carefully to effectively manage your condition.
What happens if you take overdose of Wosulin 30/70 40IU/ml Injection?
If too much of Wosulin 30/70 40IU/ml Injection is taken, it can lead to a condition called severe hypoglycemia. This is a serious situation that requires immediate medical attention. If you suspect an overdose, it is crucial to contact your doctor without delay or go to a hospital straight away. Symptoms of hypoglycemia that may result from an overdose can include fainting, feeling unwell, sweating, vomiting, difficulty breathing, a rapid heartbeat, and dizziness. It is important to act swiftly and seek help if you believe an overdose has occurred to ensure the best possible outcome for your health.
Related lab tests
When using Wosulin 30/70 40IU/ml Injection, it is important to monitor certain lab tests to ensure proper management of diabetes. One important test is HbA1C, also known as Glycated Hemoglobin or Glycosylated Hemoglobin, which provides a long-term average of blood sugar levels. Another crucial test is Blood Glucose Fasting (FBS), which measures blood sugar levels after fasting. Monitoring Insulin-Fasting levels is also recommended to assess insulin levels in the body.
Additionally, related lab tests that can be helpful include the Diabetic Checkup, which offers a comprehensive evaluation of diabetes management. The Advance Diabetes Monitoring for Senior Females is particularly beneficial for older women dealing with diabetes, providing specialized insights into their condition. Furthermore, the Jaanch Diabetic Profile Basic test offers a basic but important overview of diabetic health.
Overall, these related lab tests can assist in monitoring blood sugar levels, insulin levels, and overall diabetes management when using Wosulin 30/70 40IU/ml Injection.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹159
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024